市場調查報告書
商品編碼
1489395
到 2030 年心理健康篩檢市場預測:按產品、疾病類型、篩檢方法、年齡層、應用、最終用戶和地區進行的全球分析Mental Health Screening Market Forecasts to 2030 - Global Analysis By Product, Disease Type, Screening Method, Age Group, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球心理健康篩檢市場規模為 9.5 億美元,預計到 2030 年將達到 24.065 億美元,預測期內複合年成長率為 14.2%。
心理健康篩檢是用來評估個人心理健康並發現潛在心理健康問題的過程。這涉及使用標準化工具或調查問卷來評估心理健康的各個方面,例如情緒、焦慮和認知功能。這些篩檢由心理學家、精神科醫生和基層醫療醫生等醫療保健專業人員以及透過線上和印刷版提供的自我評估工具進行。
根據世界衛生組織 (WHO) 的數據,精神疾病佔全球 10 至 19 歲人口疾病和傷害負擔的 16%。
精神障礙盛行率上升
精神疾病盛行率的增加是心理健康篩檢市場擴張的關鍵驅動力。隨著人們對心理健康的認知和理解不斷增強,越來越多的人尋求診斷和治療。需求的激增需要有效的篩檢工具來及早發現心理健康問題。因此,醫療保健提供者正在投資創新的篩檢技術和平台來滿足這一需求。此外,社會為減少心理健康恥辱所做的努力鼓勵更多的人尋求幫助,進一步增強了對無障礙篩檢服務的需求。
偏見和看法
由於害怕判斷或歧視,圍繞心理健康問題的恥辱常常阻止人們尋求篩檢。這種社會恥辱延續了誤解,並阻礙了關於心理健康的公開討論。此外,認為心理健康篩檢是不必要的或侵入性的觀點可能會限制市場的成長,因為潛在使用者可能會認為這是侵犯隱私或核准有弱點。克服這些障礙需要進行全面的教育宣傳活動,使有關心理健康的對話變得非神聖化,並強調透過篩檢進行早期發現的重要性。
個人化篩檢解決方案
個人化篩檢解決方案的潛力在於評估個人心理健康狀況的客製化方法。我們提供可客製化的篩檢工具,以滿足每個人心理健康狀況的不同需求和細微差別。這種方法可以實現更準確的評估、及早發現問題和個人化的介入策略。透過利用人工智慧和機器學習等先進技術,個人化篩檢解決方案可以提供高效、可擴展且使用者友好的篩檢解決方案。此外,結合個人化和自訂元素可以增強使用者參與度和依從性,從而改善整體心理健康結果。在快速發展的心理健康領域,這種創新方法代表了一條有前途的途徑,可以滿足對可訪問且有效的篩檢方法日益成長的需求。
誤診
誤診的威脅是不準確地識別或標記患有精神健康狀況的個體的風險。這可能是由多種因素造成的,包括對症狀的主觀解釋、有限的評估工具以及篩檢負責人培訓。誤診可能導致不適當的治療、恥辱和症狀惡化。它也可能使人們不願意尋求幫助或接受適當的照護。減輕這種威脅需要標準化的篩檢通訊協定、負責人的持續專業發展篩檢提高對心理健康診斷複雜性的認知。
COVID-19的爆發對心理健康篩檢市場產生了重大影響,帶來了挑戰和機會。一方面,大流行造成的壓力、孤立和焦慮加劇,增加了對心理健康服務(包括篩檢)的需求,因為人們尋求心理健康支持。需求的激增使人們更加認知到心理健康篩檢和早期療育的重要性。此外,向遠距工作和虛擬醫療保健的轉變促進了數位心理健康篩檢工具和遠端保健平台的開發,為接觸需要心理健康支援的個人提供了新途徑。
遠距心理健康平台產業預計將在預測期內成為最大的產業
心理健康篩檢市場中遠距心理健康平台的成長受到多種因素的推動。首先,對心理健康問題的認知和接受程度的提高導致對可獲取和方便的篩檢選擇的需求增加。這些平台消除了恥辱和地理位置等障礙,使個人能夠在舒適的家中評估自己的心理健康狀況。此外,技術進步,特別是在遠端醫療和數位健康方面的進步,使遠距心理健康篩檢變得更加可行且方便用戶使用。智慧型手機和網路連線的普及使人們更容易使用這些平台,進一步推動了它們的成長。
預計軟體產業在預測期內複合年成長率最高
由於技術進步使市場能夠開拓可以有效評估各種心理健康狀況的先進篩檢工具,心理健康篩檢市場的軟體部分正在經歷顯著成長。這些軟體解決方案通常提供方便用戶使用的介面,使醫療保健專業人員和患者都可以輕鬆存取和使用它們。此外,人們對心理健康問題的認知不斷提高,消除污名化也推動了對篩檢服務的需求不斷成長,並導致基於軟體的解決方案的採用率提高。此外,該軟體解決方案的擴充性和成本效益使其成為醫療保健提供者和希望簡化其心理健康篩檢流程的組織的一個有吸引力的選擇。
近年來,北美心理健康篩檢市場顯著擴張。這種成長是由於人們對心理健康的認知提高和消除污名化的努力,這導致更多的人尋求篩檢服務。以精神衛生保健為重點的政府措施和醫療保健改革刺激了對篩檢基礎設施的投資。此外,COVID-19 大流行加劇了心理健康問題,並更加重視早期發現和早期療育。最後,醫療保健提供者、高科技公司和研究機構之間的合作正在推動創新並擴大市場基礎。
由於多種因素,亞太地區正在經歷顯著成長。對心理健康問題的認知和接受程度的提高正在推動對篩檢服務的需求。中國、印度和澳洲等國家的政府和醫療機構正在加大對心理健康計畫的投資,推動市場擴張。此外,該地區的人口基數,尤其都市區的人口基數,為心理健康篩檢服務提供了廣泛的市場。此外,遠距精神病學和數位篩檢工具等技術進步使心理健康服務更容易獲得,進一步推動亞太地區的市場成長。
According to Stratistics MRC, the Global Mental Health Screening Market is accounted for $950.00 million in 2023 and is expected to reach $2,406.50 million by 2030 growing at a CAGR of 14.2% during the forecast period. Mental health screening is a process used to assess an individual's psychological well-being and detect potential mental health concerns. It involves the administration of standardized tools or questionnaires to evaluate various aspects of mental health, such as mood, anxiety, and cognitive functioning. These screenings can be conducted by healthcare professionals, including psychologists, psychiatrists, or primary care physicians, as well as through self-assessment tools available online or in print.
According to the World Health Organization (WHO), mental health conditions account for 16% of the global burden of disease and injury in people aged 10-19 years.
Rising prevalence of mental disorders
The increasing prevalence of mental disorders has become a significant driver for the expansion of the mental health screening market. As awareness and understanding of mental health grow, more individuals are seeking diagnosis and treatment. This surge in demand necessitates efficient screening tools to identify mental health issues early on. Consequently, healthcare providers are investing in innovative screening technologies and platforms to meet this demand. Moreover, societal efforts to reduce stigma surrounding mental health have encouraged more people to seek help, further driving the need for accessible screening services.
Stigma and perception
Stigma surrounding mental health issues often deters individuals from seeking screening, fearing judgment or discrimination. This societal stigma can perpetuate misconceptions and hinder open discussions about mental well-being. Moreover, perceptions of mental health screening as unnecessary or intrusive can restrain market growth, as potential users may perceive it as an invasion of privacy or an acknowledgment of weakness. Overcoming these barriers requires comprehensive education campaigns to destigmatize mental health discussions and emphasize the importance of early detection through screening.
Personalized screening solutions
The Personalized Screening Solutions opportunity lies in its tailored approach to assessing individuals' mental well-being. By offering customizable screening tools, it addresses the diverse needs and nuances of each person's mental health profile. This approach can lead to more accurate assessments, early detection of issues, and personalized intervention strategies. Leveraging advanced technology like AI and machine learning, personalized screening solutions can offer efficient, scalable, and user-friendly screening solutions. Furthermore, by incorporating elements of personalization and customization, it enhances user engagement and compliance, thereby improving overall mental health outcomes. In a rapidly evolving mental health landscape, this innovative approach presents a promising avenue for addressing the growing demand for accessible and effective screening methods.
Misdiagnosis
The misdiagnosis threat is the risk of inaccurately identifying or labeling individuals with mental health conditions. This can occur due to various factors, such as subjective interpretation of symptoms, limited assessment tools, or insufficient training of screeners. Misdiagnosis can lead to inappropriate treatments, stigma, and the exacerbation of symptoms. Moreover, it may deter individuals from seeking help or receiving proper care. To mitigate this threat, there's a need for standardized screening protocols, ongoing professional development for screeners, and increased awareness about the complexities of mental health diagnoses.
The COVID-19 pandemic has significantly impacted the mental health screening market, leading to both challenges and opportunities. On one hand, the increased stress, isolation, and uncertainty caused by the pandemic have amplified the demand for mental health services, including screenings, as people seek support for their psychological well-being. This surge in demand has led to a greater recognition of the importance of mental health screening and early intervention. Additionally, the shift to remote work and virtual healthcare has prompted the development of digital mental health screening tools and telehealth platforms, presenting new avenues for reaching individuals in need of mental health support.
The remote mental health platforms segment is expected to be the largest during the forecast period
The growth of remote mental health platforms within the mental health screening market is fueled by several factors. Firstly, the increasing awareness and acceptance of mental health issues have led to a higher demand for accessible and convenient screening options. These platforms offer individuals the ability to assess their mental health from the comfort of their own homes, removing barriers such as stigma or geographical constraints. Moreover, advancements in technology, particularly in telemedicine and digital health, have made remote mental health screening more feasible and user-friendly. With the proliferation of smartphones and internet connectivity, people have greater access to these platforms, further driving their growth.
The software segment is expected to have the highest CAGR during the forecast period
The software segment within the mental health screening market has experienced significant growth due advancements in technology that enabled the development of sophisticated screening tools that can efficiently assess various mental health conditions. These software solutions often offer user-friendly interfaces, allowing for easy access and utilization by both healthcare professionals and patients. Moreover, the increasing awareness and destigmatization surrounding mental health issues have spurred greater demand for screening services, leading to a higher adoption of software-based solutions. Furthermore, the scalability and cost-effectiveness of software solutions make them attractive options for healthcare providers and organizations seeking to streamline their mental health screening processes.
In recent years, North America has witnessed a notable expansion in the mental health screening market. This growth can be attributed to increasing awareness and destigmatization efforts surrounding mental health that prompted more individuals to seek screening services. Government initiatives and healthcare reforms emphasizing mental health care have spurred investment in screening infrastructure. Furthermore, the COVID-19 pandemic has exacerbated mental health concerns, leading to a greater focus on early detection and intervention. Lastly, collaborations between healthcare providers, tech companies, and research institutions have fostered innovation and widened the market's reach.
The Asia-Pacific region has witnessed significant growth due to several factors. Increasing awareness about mental health issues, coupled with rising acceptance has fuelled the demand for screening services. Governments and healthcare organizations in countries like China, India, and Australia are investing more in mental health initiatives, driving market expansion. Additionally, the region's large population base, particularly in urban areas, presents a vast market for mental health screening services. Technological advancements, such as telepsychiatry and digital screening tools, are also facilitating easier access to mental health services, further propelling market growth in the Asia-Pacific region.
Key players in the market
Some of the key players in Mental Health Screening market include Aiberry, Apple inc., Canary speech, inc., Cognitive health solutions, Ellipsis health, inc., Google Fitbit, Headspace health, Kintsugi mindful wellness, inc., Koninklijke philips n.v., Mindwise Innovations, Modern life, inc., Quartet health, inc., Resmed inc., Sonde health, inc., Thymia limited and Total Brain.
In March 2024, ResMed announced that it launched the AirFit F40 ultra-compact, full-face mask for sleep apnea. San Diego-based ResMed designed AirFit F40 to offer the comfort of smaller masks without sacrificing performance. This could, in turn, help with sleep apnea therapy compliance for users of high-pressure continuous positive airway pressure (CPAP) treatment.
In November 2023, Ellipsis Health announced its sponsorship of the Asia-Pacific Economic Cooperation (APEC) Summit, highlighting its commitment to improving mental healthcare in San Francisco and beyond and raising awareness for access to treatment for all communities.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.